Beyond the questionnaire, to a signal.
Pain has long been assessed by asking. DatChem-Pain reads its chemistry directly from tissue, turning a subjective report into an objective measurement.
That signal distinguishes acute pain from chronic pain, and can be tracked over time to show whether a treatment is actually working.
- Objective assessment. A measured signal in place of a self-reported score.
- Acute vs chronic. Distinguishes the two states from their chemistry.
- Treatment monitoring. Tracks whether a therapy is genuinely working.
Backed by granted US patents covering the detection of pain and the monitoring of its transition from acute to chronic.
What an objective signal makes possible.
Objective
A measured chemical signal, not a number on a scale, pain you can actually see.
Acute vs chronic
Tells acute pain from chronic pain, and flags the transition between them.
Treatment monitoring
Tracked over time to show whether a treatment is genuinely working.
From scan to report, on existing scanners.
DatChem-Pain adds a short sequence to a standard MRI, no new hardware, with results returned to the physician in minutes.
Patient scan
A short scan in a standard MRI captures the raw spectral data, no contrast, no biopsy.
Data capture
Raw data is transmitted securely from the scanner to the DatChem cloud, region by region.
Data processing
The chemical signature is extracted and compared against our exclusive databases.
Physician report
A report gives an objective pain signal, distinguishing acute from chronic over time.
DatChem's technologies are undergoing regulatory evaluation (TGA, FDA and EMA) and are not yet approved for routine clinical use in all markets.
Bring DatChem-Pain to your centre.
For clinical, research or partnership enquiries about DatChem-Pain, we'd be glad to hear from you.